Document Detail

Detection of human coronaviruses in simultaneously collected stool samples and nasopharyngeal swabs from hospitalized children with acute gastroenteritis.
Jump to Full Text
MedLine Citation:
PMID:  23379823     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
ABSTRACT: BACKGROUND: Human coronaviruses (HCoVs) are a well-known cause of respiratory infections but their role in gastrointestinal infections is unclear. The objective of our study was to assess the significance of HCoVs in the etiology of acute gastroenteritis (AGE) in children <6 years of age. METHODS: Stool samples and nasopharyngeal (NP) swabs collected from 260 children hospitalized for AGE (160 also had respiratory symptoms) and 157 otherwise healthy control children admitted for elective surgery were tested for the presence of four HCoVs using real time RT-PCR. Registered at ClinicalTrials.gov (reg. NCT00987519). RESULTS: HCoVs were more frequent in patients with AGE than in controls (23/260, 8.8% versus 4/151, 2.6%; odds ratio, OR 3.3; 95% confidence interval, CI 1.3--10.0; P = 0.01). Three of four HCoV-positive members in the control group, asymptomatic when sampled, recalled gastrointestinal or respiratory symptoms within the previous 14 days. In patients with AGE, HCoVs were present in NP samples more often than in stools (22/256, 8.6%, versus 6/260, 2.3%; P = 0.0004). In 5/6 children with HCoVs detected in stools, the viruses were also detected in NP swabs. Patients had a significantly higher probability of HCoV detection in stool (OR 4; 95% CI 1.4--15.3; P = 0.006) and also in stool and/or NP (OR 3.3, 95% CI 1.3--10.0; P = 0.01) than healthy controls. All four HCoVs species were detected in stool and NP samples. CONCLUSIONS: Although HCoVs were more frequently detected in patients with AGE than in the control group, high prevalence of HCoVs in NP swabs compounded by their low occurrence in stool samples and detection of other viruses in stool samples, indicate that HCoVs probably play only a minor role in causing gastrointestinal illness in children <6 years old.
Authors:
Monika Jev Nik; Andrej Steyer; Tamara Zrim; Marko Pokorn; Tatjana Mrvi; Tefan Grosek; Franc Strle; Lara Lusa; Miroslav Petrovec
Related Documents :
11986453 - Effectiveness and efficacy of zinc for the treatment of acute diarrhea in young children.
18562593 - Pediatric norovirus diarrhea in nicaragua.
1174403 - Anterior chamber depth and primary angle-closure glaucoma. ii. a genetic study.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-2-5
Journal Detail:
Title:  Virology journal     Volume:  10     ISSN:  1743-422X     ISO Abbreviation:  Virol. J.     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-2-5     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101231645     Medline TA:  Virol J     Country:  -    
Other Details:
Languages:  ENG     Pagination:  46     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Full Text
Journal Information
Journal ID (nlm-ta): Virol J
Journal ID (iso-abbrev): Virol. J
ISSN: 1743-422X
Publisher: BioMed Central
Article Information
Download PDF
Copyright ©2013 Jevšnik et al.; licensee BioMed Central Ltd.
open-access:
Received Day: 25 Month: 7 Year: 2012
Accepted Day: 30 Month: 1 Year: 2013
collection publication date: Year: 2013
Electronic publication date: Day: 5 Month: 2 Year: 2013
Volume: 10First Page: 46 Last Page: 46
PubMed Id: 23379823
ID: 3610273
Publisher Id: 1743-422X-10-46
DOI: 10.1186/1743-422X-10-46

Detection of human coronaviruses in simultaneously collected stool samples and nasopharyngeal swabs from hospitalized children with acute gastroenteritis
Monika Jevšnik1 Email: monika.jevsnik@mf.uni-lj.si
Andrej Steyer1 Email: andrej.steyer@mf.uni-lj.si
Tamara Zrim1 Email: tamara.zrim@mf.uni-lj.si
Marko Pokorn2 Email: marko.pokorn@mf.uni-lj.si
Tatjana Mrvič2 Email: tatjana.mrvic@guest.arnes.si
Štefan Grosek3 Email: stefan.grosek@kclj.si
Franc Strle2 Email: franc.strle@kclj.si
Lara Lusa4 Email: lara.lusa@mf.uni-lj.si
Miroslav Petrovec1 Email: mirc.petrovec@mf.uni-lj.si
1Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Zaloška 4, 1000 Ljubljana, Slovenia
2Department of Infectious Diseases, University Medical Centre Ljubljana, Japljeva 2, 1525 Ljubljana, Slovenia
3Department of Pediatric Surgery and Intensive Care, University Medical Centre Ljubljana, Bohoričeva 20, 1000 Ljubljana, Slovenia
4Institute of Biostatistics and Medical Informatics, Faculty of Medicine, Vrazov trg 2, 1104 Ljubljana, Slovenia

Background

Human coronaviruses (HCoVs), known since the late 1960s, have been recognized as a frequent cause of mild respiratory tract infections (RTIs) and occasionally as a potential cause of severe lower RTI in premature infants and children with underlying diseases [1]. Their role in enteric infections is less clear. Even though coronavirus-like particles have been seen by electron microscopy in stool samples from patients with diarrhea, they have been also found in healthy individuals [2]. However, coronaviruses are associated with diarrheal disease in several animal species. Thus, a dual enteric and respiratory tropism has been reported for the bovine coronavirus causing winter dysentery in calves [3]. Interest in coronaviruses in relation to enteric diseases in humans increased with the emergence of severe acute respiratory syndrome (SARS) and identification of SARS-CoV in 2003 [4,5]. SARS was characterized clinically by signs/symptoms of severe lower RTI but several patients also had gastrointestinal complaints [6,7]. Diarrhea has also been a prominent clinical feature in several patients with respiratory infection caused by other HCoVs [8-10]. Furthermore, all HCoV species were recently detected in stool samples of patients with acute gastroenteritis (AGE) by modern molecular methods, but their role in human gastrointestinal infections remains uncertain [11-13]. In previous studies, HCoVs were demonstrated in patients with gastrointestinal and/or respiratory involvement, but in none of these studies was concurrent collection of stool and respiratory samples performed. The main objective of the present study was to evaluate the presence of HCoVs in simultaneously collected stool samples and nasopharyngeal (NP) swabs in children with AGE (with or without associated respiratory symptoms) and in control subjects, with the aim of appraising their role in the etiology of AGE.


Results
Patients

From October 2009 to September 2011, 765 children <6 years of age were referred to the Department of Infectious Disease with the diagnosis of AGE. Of them 260 were enrolled in the study. The others did not meet inclusion criteria for AGE (250 children), were not enrolled because their parents did not consent with the inclusion in the study (182 children) or because they did not pass stool during hospital stay (73 children). The median age of included children was 18.9 months. The female: male subject ratio was 1: 1.13 (122/260; 46.9% girls). In 100 of the subjects (39.5%), signs and symptoms were limited to the gastrointestinal tract, while 160 (61.5%) also had signs and symptoms compatible with acute RTI such as rhinitis, pharyngitis, conjunctivitis, otitis or bronchiolitis.

In the group of children with AGE, both samples (stool sample and NP swab) were obtained from 256/260 patients (only stool sample was acquired from four of them). From 157 children comprising the healthy control group, both samples were available from 150 patients, only a stool sample from one child and only a NP swab from six.

Samples obtained at follow-up examination 14 days after initial testing were available for 192/260 (73.8%) children with AGE. Unfortunately, 68 remaining children did not respond and did not come to follow up visit 14 days after acute illness. Children who did not come to the follow up visit had similar clinical characteristics as those who attended the follow up visit. Therefore, authors assumed that they were representative of the entire study population. In 174 of the patients, both stool and NP swab samples were obtained, while only stool sample was obtained from nine children and solely NP swab was available from nine others.

Detection of HCoVs in stool samples and NP swabs of patients with AGE

HCoVs were detected in 6/260 stool samples from children with AGE (2.3%; 95% CI 0.9–5.0%)—among which 5/6 were detected also in NP samples—and in 22/256 NP swabs (8.6%, 95% CI 5.5–12.7%). HCoVs were more often detected in NP swabs than in stool samples (P = 0.0004 by McNemar’s test).

Four of six (67%, 95% CI 22–96%) children with HCoV-positive stool samples had symptoms of respiratory and gastrointestinal infection (Table  1). Of the six HCoV-positive stool samples, three were characterized as OC43, one as NL63, one as HKU1 and one as 229E. In two (33.3%) stool samples HCoV (one 229E and one OC43) was detected as a single pathogen, while in four samples the presence of other viruses was also established (Table  2).

Of 22 positive NP samples, 13 (59%, 95% CI 36–79%) originated from children with AGE associated with RTI. The species distribution was as follows: nine OC43 (41%), seven HKU1 (32%), three 229E (14%) and three NL63 (14%; Table  2). Fifteen (68.2%) of 22 HCoVs positive NP swabs were detected as a single viral pathogen; also in this subgroup the most common was OC43 (7/15, 46.7%). HCoVs was detected as a single viral pathogen in NP swab in 8/9 (88.9%) children with AGE as the only clinical sign and in 7/13 (53.8%) NP swabs of children who had AGE associated with signs/symptoms of RTI (OR = 6.3; 95% CI 0.5- 353; P = 0.16).

HCoVs were not detected in any of 183 follow-up stool samples. Of 183 follow-up NP swabs, 15 (8.2%, 95% CI 4.7–13.1%) were positive for HCoVs: eight were typed as HKU1, four as NL63 and two as OC43; one positive sample remained untyped because of the low viral load. In 10 of 15 positive children, HCoVs were demonstrated only in the follow-up sample, while in five children the presence of HCoVs was established in the first and follow-up NP swab; four of these also had HCoVs in stools at the first sampling (Table  2). At the time of follow-up testing, 1/15 children (7%, 95% CI 0.2–31.9%) with HCoV-positive NP swab had gastrointestinal signs/symptoms; 10/15 (67%, 95% CI 38–88%) had RTI and four (26.7%, 95% CI 8–55%) were asymptomatic.

None of the 38 samples from 33 children positive for HCoVs in NP swabs and/or stool sample had viruses detected in blood sample taken simultaneously.

Control group

HCoVs were detected in 1/151 stool samples (0.7%, 95% CI 0–3.6%) and in 3/150 NP swabs (1.9%, 95% CI 0.4–5.7%) from the control group. The HCoV from the stool sample remained untyped whereas respiratory samples revealed one NL63, one 229E and one HCoV that was untyped. HCoVs remained untyped because of the low viral load. All 151 children included in the control group were asymptomatic on the day of sampling; however a detailed history showed that three out of four children who were found to be HCoV positive reported symptoms indicating respiratory or gastrointestinal infections within 14 days before sampling.

Patients with AGE had a significantly higher probability of HCoV detection in stool samples than controls (OR 4; 95% CI 1.4–15.3; P = 0.006), while a weaker association was observed using NP samples (OR 2.6; 95% CI 0.5–24.7; P = 0.26). If positive stool samples and/or NP swabs were considered together, the association remained statistically significant (OR 3.3; 95% CI 1.3–10.0; P = 0.01).


Discussion

HCoVs are recognized as causes of respiratory infections but their role in gastrointestinal infections has not been clarified. In the present study we assessed the significance of HCoVs in the etiology of AGE in children <6 years old by testing samples from stools and NP swabs for the presence of four HCoVs by RT–PCR. In the patients with AGE, follow-up sampling was performed 14 days after the initial testing and we acquired detailed clinical information for each participant. Our study revealed that HCoVs were present in patients with AGE and that viruses were more prevalent in the patients than in the control group (23/260, 8.8% versus 4/151, 2.6%, OR 3.3, 95% CI 1.3–10.0%, P = 0.01). Moreover, the higher probability of HCoV detection in the stool samples of patients with AGE than among controls (OR 4; 95% CI 1.4–15.3; P = 0.006) indicated a causal association of HCoVs with AGE. This was supported by the observation that three of four HCoV-positive members of the control group, who were asymptomatic at the time of sampling, reported symptoms within a 14-day period before sampling. However, in patients with AGE one would think that the etiologic agent is more likely to be demonstrated predominantly in stool samples, whereas in our study HCoVs were detected more often in NP swabs than in stools (22/256, 8.6% versus 6/260, 2.3%; P = 0.0004). In addition, in five of six children with HCoVs detected in the stool samples, the viruses were also demonstrated in NP swabs. There are several partial explanations for this. The course of the events in HCoVs infection might have been similar to those known to be operative in animals and as suggested for SARS-CoV [6,14]. Thus, fecal–oral transmission is followed by intestinal damage, leading to viremia and respiratory infection. However, we tested all patients with HCoVs found in stool samples or NP swabs for the presence of the viruses in blood but did not get any positive result. In addition, viremia usually results in the involvement of the lower RTI whereas upper RTI is usually the result of direct spread of infection through neighboring tissues. Although we cannot exclude viremia that was missed in our patients, it seems more likely that HCoVs did not cause viremia. The other possibility is that oral transmission of HCoVs is followed by gastrointestinal infection in patients with AGE and in the majority of children by symptomatic or asymptomatic NP infections because of the direct spread of viruses from the oral cavity to the nasopharynx, or secondarily from the gastrointestinal region from vomiting (69.6% of our children experienced vomiting in addition to diarrhea). Because enveloped HCoVs viruses are not stable in stools, their persistence is much more limited and transient than in the upper respiratory tract. This could explain the lower detection rate of HCoVs in stools than in NP swabs. The third possibility is that the primary location of HCoVs replication is in the nasopharynx, resulting in asymptomatic or symptomatic respiratory infections, and that the HCoVs occasionally found in stool samples had their origin in the respiratory system but were passed down the alimentary tract. This theory would enable an elegant explanation for the higher proportion of NP swabs positive for HCoVs than in stools and for the finding that all but one patient with HCoVs in the stool samples also had them present in NP swabs, but does not explain AGE, which should have been caused by other agent. The theory is further supported by the finding that only in two children HCoVs were found as a sole viral agent in stool while in four cases the presence of other viruses known to cause AGE was also established. Surprisingly, HCoVs were detected as a single viral pathogen in 8/9 (88.9%) NP swabs from children with AGE without concomitant respiratory symptoms.

More than half (160/260, 61.5%) of children with AGE also had respiratory symptoms at the time of sampling. This proportion was similar for patients with HCoV-positive NP swabs (59.1%) and for those with HCoV-positive stool samples (66.7%), whereas it was higher (80%) for children with HCoVs detected in both samples. However, there were very few patients with HCoVs in stool samples and with viruses found in both sources (six and five, respectively) and the difference was not statistically significant. In a report from Finland, 50% of children with AGE and HCoV-positive stool samples had respiratory symptoms at the time of sampling, while in a study from the USA both symptoms appeared in 75% of children [11,13]. The median duration of illness and of hospitalizations were similar for HCoVs positive and negative children (Table  1), and the differences were not statistically significant (duration of illness: P = 0.91 for stool samples, P = 0.63 for NP swabs, duration of hospitalization: P = 0.11 for stool samples and P = 0.13 for NP swabs).

No significant difference was found between the proportion of HCoVs present at the time of acute illness and 14 days later (23/260, 8.8%, versus 15/183, 8.2%, P = 0.54). A more detailed analysis of follow-up samples revealed that the presence of HCoVs in all 15 children was limited to NP swabs, that only 5/15 (33.3%) children had been positive for HCoVs in the first sample and that in 4/5 of them HCoVs were found in NP swabs as well as in stool samples. The last finding suggests that the persistence of HCoVs in NP swabs is associated with positivity of both samples (NP swabs and stools) during an acute illness.

Information on the occurrence of HCoVs in healthy persons is limited. Our finding that HCoVs were rare in stool samples from healthy children (0.7%, 95% CI 0–3.6%) and in NP swabs (1.9%, 95% CI 0.4–5.7%) is consistent with a report finding HCoVs in only 1.8% of stools from healthy children [11].

All four HCoVs species were detected in stool and NP samples; the most common was OC43 (50% in stool samples, 41% in NP samples). 229E occurred only in children with AGE without respiratory symptoms, whereas NL63 was found only in children with RTI as an additional sign.


Conclusions

In conclusion, the presence of HCoVs in patients with AGE, the more frequent demonstration of these viruses in patients than in the control group and the higher probability of HCoVs detection in the stools of patients with AGE than in controls indicates some causal association of HCoVs with AGE. However, interpretation of the role of HCoVs in AGE is complex because the viruses were more often demonstrated in NP swabs than in stool samples, because of detection of other viruses known to cause AGE in stool samples and because more than half of the children with AGE had also signs and symptoms of RTI. The findings of the present study suggest that HCoVs probably played only a minor role in gastrointestinal illness in these children.


Methods
Study design

This was a part of a prospective study on viral respiratory and gastrointestinal infections in children <6 years. Children in this age group who had been admitted to the Department of Infectious Diseases of the University Medical Centre Ljubljana, from October 2009 to September 2011, with the diagnosis of AGE (defined as the passage of three or more loose or liquid stools in 24 h) were eligible for the study. Stool specimens, NP swabs and blood samples were obtained at admission and at a follow-up visit 14 days after the initial sampling. Children in the same age group admitted to the Department of Pediatric Surgery and Intensive Care for planned elective surgical procedures (i.e. inguinal hernia repair, testicular retention or hydrocele) were selected as a healthy control group. Only children without infections in last four weeks preceding the surgery were eligible for surgery admission. All children were clinically examined and only those without any symptoms of infection were admitted. Approximately one third of the admitted children have not been included due to parents’ refusal of entering the study or due to logistical problems with sample collection. In this group, stool samples and NP swabs were collected at admission. At this time, information was obtained on the presence of signs and symptoms compatible with gastrointestinal and/or respiratory infection within the last 14 days. To minimize children’s discomfort nasopharyngeal sampling was performed after patients underwent anesthesia.

The study protocol was approved by the National Medical Ethics Committee of the Republic of Slovenia (No. 87/08/09). Written informed consent was obtained from all parents of participating patients and control subjects. The principles of the Helsinki Declaration, the Oviedo Convention on Human Rights and Biomedicine and the Slovene Code of Medicine Deontology were strictly followed in the conduct of this research. The study protocol was also submitted to ClinicalTrials.gov registry with the title Viral respiratory and Gastrointestinal Infections in Children Under 6 Years of Age (reg. NCT00987519).

Laboratory methods

Stool samples were diluted in sterile phosphate-buffered saline (PBS) to a 10% suspension. Aliquots of 180 μL of MagNA Pure bacteria lysis buffer (Roche Applied Science, Mannheim, Germany) and 20 μL of proteinase K (Qiagen, Hilden, Germany) were added to 190 μL of stool suspension.

NP swabs were collected using flocked-tip swabs and transported to the laboratory in the Copan universal transport medium (UTM-RT) system (Copan Italia, Brescia, Italy).

Before the extraction procedure, 5 μL of Equine herpesvirus 1 and 5 μL of Equine arthritis virus isolates were added to all samples. Specific target sequences of these viruses were subsequently amplified in separate real time reverse transcription polymerase chain reactions (RT–PCRs) as an internal control to ensure that negative results were not caused by poor nucleic acid extraction or inhibition of the RT–PCR assay [15,16].

The initial volume used for extracting total nucleic acids was 400 μL of stool suspension, 190 μL of vigorously vortexed NP swab medium and 190 μL of whole blood samples. Nucleic acids were extracted using total nucleic acid isolation kits on a MagNa Pure Compact instrument (Roche Applied Science), according to the manufacturer’s instructions.

Coronaviruses including HKU1, NL63, 229E and OC43 were detected in stool samples, NP swabs and whole blood samples by molecular methods using primers and probes as described by Kuypers et al. [17]. For amplification of 85–100 bp fragments of the polymerase 1b gene of coronaviruses, a one-step real-time RT–PCR assay was used in a StepOne Real-Time PCR system (Applied Biosystems, Carlsbad, CA). Briefly, 5 μL of total nucleic acid was added to 15 μL of reaction mixture including 2 × Reaction Mix, SuperScript® III RT/Platinum® Taq Mix (Invitrogen, Carlsbad, CA) with an additional 6 mM MgSO4. The cycling conditions were as follows: 20 min at 50°C, 2 min at 95°C and 45 cycles of 15 s at 95°C and 45 s at 60°C.

All NP swabs and stool samples in which HCoVs were established were also tested for the presence of other viruses. In NP swabs respiratory syncytial virus (RSV), influenza viruses A and B (Flu A-B), parainfluenza viruses 1–3 (PIV 1–3), metapneumovirus (hMPV), human bocavirus (HBoVs), adenovirus (AdV) and rhinovirus (hRV) [18-24] were searched for by real-time RT-PCR. Stool samples were tested for the presence of HBoVs and AdV using molecular methods as described previously [22,23], and for other gastroenteric viruses by electron microscopy (EM). The presence of norovirus genogroups I and II and astrovirus was ascertained by real-time RT-PCR [25,26], while group A rotavirus and adenovirus type 40/41 were detected by antigen-ELISA Premier Rotaclone and Premier Adenoclone (Meridian Bioscience, Cincinnati, OH).

Statistical analysis

Data are reported as the frequency (percentage) and 95% confidence intervals (CIs) for proportions obtained using exact binomial tail areas. McNemar’s test was used to compare the frequency of HCoV positivity of patients at baseline and after 14 days of follow-up. Univariate logistic regression models with Firth’s correction were used to assess the association between HCoV positivity and study group (patient or control) and the results are reported as the odds ratio (OR) with 95% CI and two-sided P values. Mann–Whitney test was used to compare the median duration of illness and of hospitalization of HCoVs positive and HCoVs negative children.


Abbreviations

HCoVs: Human coronaviruses; NP swab: Nasopharyngeal swab; RTI: Respiratory tract infections; AGE: Acute gastroenteritis.


Competing interests

The authors declare that they have no competing interests. This study was supported by the Slovenian Research Agency (Research Program P3-0083) and institutional department funds.


Authors’ contributions

MJ, MP2, TM, ŠG, FS and MP1 created the original idea of this research. MJ, AS, LL, TM, MP2, FS and MP1 designed the study and conducted analysis and interpretation of the data. TZ performed some of the laboratory methods. All authors read and approved the final manuscript.


References
Monto AS,Lim SK,The Tecumseh study of respiratory illness VI. Frequency of and relationship between outbreaks of coronavirus infectionJ Infect DisYear: 197412927127610.1093/infdis/129.3.2714816305
Clarke SK,Caul EO,Egglestone SI,The human enteric coronavirusesPostgrad Med JYear: 19795513514210.1136/pgmj.55.640.135461276
Park SJ,Kim GY,Choy HE,Hong YJ,Saif LJ,Jeong JH,Park SI,Kim HH,Kim SK,Shin SS,Kang MI,Cho KO,Dual enteric and respiratory tropisms of winter dysentery bovine coronavirus in calvesArch VirolYear: 20071521885190010.1007/s00705-007-1005-217564760
Drosten C,Gunther S,Preiser W,van der Werf S,Brodt HR,Becker S,Rabenau H,Panning M,Kolesnikova L,Fouchier RA,Berger A,Burguiere AM,Cinatl J,Eickmann M,Escriou N,Grywna K,Kramme S,Manuguerra JC,Muller S,Rickerts V,Sturmer M,Vieth S,Klenk HD,Osterhaus AD,Schmitz H,Doerr HW,Identification of a novel coronavirus in patients with severe acute respiratory syndromeN Engl J MedYear: 20033481967197610.1056/NEJMoa03074712690091
Peiris JS,Lai ST,Poon LL,Guan Y,Yam LY,Lim W,Nicholls J,Yee WK,Yan WW,Cheung MT,Cheng VC,Chan KH,Tsang DN,Yung RW,Ng TK,Yuen KY,Coronavirus as a possible cause of severe acute respiratory syndromeLancetYear: 20033611319132510.1016/S0140-6736(03)13077-212711465
Leung WK,To KF,Chan PK,Chan HL,Wu AK,Lee N,Yuen KY,Sung JJ,Enteric involvement of severe acute respiratory syndrome-associated coronavirus infectionGastroenterologyYear: 20031251011101710.1016/j.gastro.2003.08.00114517783
Peiris JS,Chu CM,Cheng VC,Chan KS,Hung IF,Poon LL,Law KI,Tang BS,Hon TY,Chan CS,Chan KH,Ng JS,Zheng BJ,Ng WL,Lai RW,Guan Y,Yuen KY,Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective studyLancetYear: 20033611767177210.1016/S0140-6736(03)13412-512781535
Esposito S,Bosis S,Niesters HG,Tremolati E,Begliatti E,Rognoni A,Tagliabue C,Principi N,Osterhaus AD,Impact of human coronavirus infections in otherwise healthy children who attended an emergency departmentJ Med VirolYear: 2006781609161510.1002/jmv.2074517063525
Leung TF,Li CY,Lam WY,Wong GW,Cheuk E,Ip M,Ng PC,Chan PK,Epidemiology and clinical presentations of human coronavirus NL63 infections in hong kong childrenJ Clin MicrobiolYear: 2009473486349210.1128/JCM.00832-0919759228
Woo PC,Lau SK,Tsoi HW,Huang Y,Poon RW,Chu CM,Lee RA,Luk WK,Wong GK,Wong BH,Cheng VC,Tang BS,Wu AK,Yung RW,Chen H,Guan Y,Chan KH,Yuen KY,Clinical and molecular epidemiological features of coronavirus HKU1-associated community-acquired pneumoniaJ Infect DisYear: 20051921898190710.1086/49715116267760
Risku M,Lappalainen S,Rasanen S,Vesikari T,Detection of human coronaviruses in children with acute gastroenteritisJ Clin VirolYear: 201048273010.1016/j.jcv.2010.02.01320233673
Vabret A,Dina J,Gouarin S,Petitjean J,Corbet S,Freymuth F,Detection of the new human coronavirus HKU1: a report of 6 casesClin Infect DisYear: 20064263463910.1086/50013616447108
Esper F,Ou Z,Huang YT,Human coronaviruses are uncommon in patients with gastrointestinal illnessJ Clin VirolYear: 20104813113310.1016/j.jcv.2010.03.00720362494
Azevedo MS,Yuan L,Jeong KI,Gonzalez A,Nguyen TV,Pouly S,Gochnauer M,Zhang W,Azevedo A,Saif LJ,Viremia and nasal and rectal shedding of rotavirus in gnotobiotic pigs inoculated with Wa human rotavirusJ VirolYear: 2005795428543610.1128/JVI.79.9.5428-5436.200515827157
Diallo IS,Hewitson G,Wright L,Rodwell BJ,Corney BG,Detection of equine herpesvirus type 1 using a real-time polymerase chain reactionJ Virol MethodsYear: 2006131929810.1016/j.jviromet.2005.07.01016137772
Mankoc S,Hostnik P,Grom J,Toplak I,Klobucar I,Kosec M,Barlic-Maganja D,Comparison of different molecular methods for assessment of equine arteritis virus (EAV) infection: a novel one-step MGB real-time RT-PCR assay, PCR-ELISA and classical RT-PCR for detection of highly diverse sequences of Slovenian EAV variantsJ Virol MethodsYear: 200714634135410.1016/j.jviromet.2007.07.01917854913
Kuypers J,Martin ET,Heugel J,Wright N,Morrow R,Englund JA,Clinical disease in children associated with newly described coronavirus subtypesPediatricsYear: 2007119e70e7610.1542/peds.2006-140617130280
Kuypers J,Wright N,Morrow R,Evaluation of quantitative and type-specific real-time RT-PCR assays for detection of respiratory syncytial virus in respiratory specimens from childrenJ Clin VirolYear: 20043112312910.1016/j.jcv.2004.03.01815364268
Kuypers J,Wright N,Ferrenberg J,Huang ML,Cent A,Corey L,Morrow R,Comparison of real-time PCR assays with fluorescent-antibody assays for diagnosis of respiratory virus infections in childrenJ Clin MicrobiolYear: 2006442382238810.1128/JCM.00216-0616825353
Daum LT,Canas LC,Arulanandam BP,Niemeyer D,Valdes JJ,Chambers JP,Real-time RT-PCR assays for type and subtype detection of influenza A and B virusesInfluenza Other Respi VirusesYear: 2007116717510.1111/j.1750-2659.2007.00024.x19432632
Maertzdorf J,Wang CK,Brown JB,Quinto JD,Chu M,de Graaf M,van den Hoogen BG,Spaete R,Osterhaus AD,Fouchier RA,Real-time reverse transcriptase PCR assay for detection of human metapneumoviruses from all known genetic lineagesJ Clin MicrobiolYear: 20044298198610.1128/JCM.42.3.981-986.200415004041
Lu X,Chittaganpitch M,Olsen SJ,Mackay IM,Sloots TP,Fry AM,Erdman DD,Real-time PCR assays for detection of bocavirus in human specimensJ Clin MicrobiolYear: 2006443231323510.1128/JCM.00889-0616954253
De Vos N,Vankeerberghen A,Vaeyens F,Van Vaerenbergh K,Boel A,De Beenhouwer H,Simultaneous detection of human bocavirus and adenovirus by multiplex real-time PCR in a Belgian paediatric populationEur J Clin Microbiol Infect DisYear: 2009281305131010.1007/s10096-009-0780-y19705175
Scheltinga SA,Templeton KE,Beersma MF,Claas EC,Diagnosis of human metapneumovirus and rhinovirus in patients with respiratory tract infections by an internally controlled multiplex real-time RNA PCRJ Clin VirolYear: 20053330631110.1016/j.jcv.2004.08.02115994117
Kageyama T,Kojima S,Shinohara M,Uchida K,Fukushi S,Hoshino FB,Takeda N,Katayama K,Broadly reactive and highly sensitive assay for Norwalk-like viruses based on real-time quantitative reverse transcription-PCRJ Clin MicrobiolYear: 2003411548155710.1128/JCM.41.4.1548-1557.200312682144
Svraka S,van der Veer B,Duizer E,Dekkers J,Koopmans M,Vennema H,Novel approach for detection of enteric viruses to enable syndrome surveillance of acute viral gastroenteritisJ Clin MicrobiolYear: 2009471674167910.1128/JCM.00307-0919339472

Tables
[TableWrap ID: T1] Table 1 

RT–PCR positivity for HCoVs according to sample type and clinical presentation


  HCoVs stool positive HCoVs stool negative HCoVs NP swab positive HCoVs NP swab negative Both stool and NP swab HCoVs positive
Patients
6/260 (2.3%, 95% CI 0.9–5.0%)
254/260 (97.7%, 95% CI 95-99%)
22/256 (8.6%, 95% CI 5.5–12.7%)
234/256 (91.4%, CI 87-95% )
5/256 (1.9%, 95% CI 0.6-4.5%)
AGE only
2/6, (33%, 95% CI 4.3–78%)
98/254 (38.6%, 95% CI: 33-45% )
9/22 (41%, 95% CI 21–64%)
87/234 (3.2%, CI 31-44%)
1/5, (20%. 95% CI 0.5–72%)
AGE + RTI
4/6 (66.7%, 95% CI 22–96%)
156/254 (61.4%, 95% CI: 55-67%)
13/22 (59%, 95% CI 36–79%)
147/234 (62.8%, 95 CI 56-69%)
4/5, (80%, 95% CI 28–99%)
Vomiting
6/6 (100%, 95% CI 54-100%)
201/254 (79.1%, 95% CI 74-84%)
15/22 (68.2%, 95% CI 45-86%)
188/234 (80.3%, 95% CI 75-85%)
5/5 (100%, 95% CI 48-100% )
Median duration of illness (days)
5.5 (range 4–16)
6 (range 1–18)
5 (range 1–16)
6 (range 1–18)
5 (range 4–16)
Median duration of hospitalization (days)
3 (range 2–6)
2 (range 1–11)
2.5 (range 1–6)
2 (range 1–11)
3 (range 2–6)
Controls 1/151 (0.7%, 95% CI 0–3.6%) 150/151 (99.3%, 95% CI 96.4-100%) 3/150 (1.9%, 95% CI 0.4–5.7%) 147/150 (98%, 95% CI 94.3-99.6%) 0

Key: AGE, acute gastroenteritis; RTI, respiratory tract infection; NP, nasopharyngeal.


[TableWrap ID: T2] Table 2 

Patients with HCoVs demonstrated in stool samples and/or NP swabs at initial testing: information on clinical signs, viral species and results of follow-up testing


Patient Clinical signs HCoVs species in stool samples Other viruses in stool samples HCoVs species in NP swab Other viruses in NP swab Follow up stool sample Follow up NP swab
1
AGE + RTI
OC43
neg
OC43
neg
neg
HKU1*
2
AGE + RTI
OC43
Norovirus
OC43
neg
neg
neg
3
AGE + RTI
OC43
Rotavirus, AdV
OC43
AdV
AdV
OC43, AdV
4
AGE + RTI
NL63
Rotavirus
NL63
hRV
neg
NL63, hRV, PIV*
5
AGE
HKU1
SRV
OC43
HBoV, hRV, PIV
neg
HKU1**
6
AGE
229E
neg
neg
neg
neg
neg
7
AGE + RTI
neg
neg
OC43
neg
neg
neg
8
AGE + RTI
neg
neg
OC43
neg
NA
NA
9
AGE + RTI
neg
neg
NL63
hRV
neg
neg*
10
AGE + RTI
neg
Astrovirus
NL63
RSV, INF A
neg
neg
11
AGE + RTI
neg
Rotavirus
HKU1
neg
neg
RSV,PIV*
12
AGE + RTI
neg
Rotavirus
HKU1
neg
NA
NA
13
AGE + RTI
neg
AdV
HKU1
AdV, RSV
NA
NA
14
AGE + RTI
neg
Rotavirus, AdV
HKU1
neg
neg
hRV
15
AGE + RTI
neg
Norovirus, AdV
HKU1
AdV, HBoV
neg
neg
16
AGE
neg
neg
OC43
neg
neg
neg
17
AGE
neg
neg
229E
neg
neg
neg
18
AGE
neg
Rotavirus
OC43
neg
neg
neg
19
AGE
neg
Rotavirus, AdV
OC43
neg
neg
NA
20
AGE
neg
Rotavirus
HKU1
neg
neg
neg
21
AGE
neg
Norovirus, AdV
HKU1
neg
AdV**
HKU1
22
AGE
neg
Rotavirus, AdV
229E
neg
neg
RSV*
23 AGE neg Rotavirus 229E neg neg neg

Key: *RTI, respiratory tract infection; **AGE, acute gastroenteritis; OC43; human coronavirus OC43; NL63, human coronavirus NL63; HKU1, human coronavirus HKU1; 229E, human coronavirus 229E; AdV, adenovirus; hRV, rinovirus; PIV, parainfluenza virus; SRV, small round viruses; RSV, respiratory syncytial virus; INF A, influenza virus A; neg, negative; NA, sample not available.



Article Categories:
  • Research

Keywords: Human coronavirus, Viral gastroenteritis, Respiratory infection.

Previous Document:  Chitosan-based systems for intranasal immunization against foot-and-mouth disease.
Next Document:  Skin Grafts Provide Durable End-bearing Coverage for Lower-extremity Amputations With Critical Soft ...